How does a health technology assessment (HTA) tool help to guide the pricing of pharmaceutical products?
Unlike many other countries, the United States does not regulate drug prices—and in 2015 drug prices there typically ran 1.5 to 3 times higher than those in other developed countries. This case asks students to analyze an actual health assessment tool for Harvoni®, a drug to treat Hepatitis C, in order to determine the best recommended pricing for this new product.
Case ID: 160311
Buy select cases through Ivey Publishing and Harvard Business Publishing.
Contact us by e-mail at Columbia CaseWorks or 212-853-8585.